Go Pro
OTCMKTS:MRMD

MariMed (MRMD) Stock Price, News & Analysis

MariMed logo
$0.07 0.00 (-0.91%)
As of 03:59 PM Eastern

About MariMed Stock (OTCMKTS:MRMD)

Advanced

Key Stats

Today's Range
$0.06
$0.07
50-Day Range
$0.07
$0.09
52-Week Range
$0.06
$0.23
Volume
628,827 shs
Average Volume
255,946 shs
Market Capitalization
$26.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

MariMed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

MRMD MarketRank™: 

MariMed scored higher than 33% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MariMed has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MariMed has received no research coverage in the past 90 days.

  • Read more about MariMed's stock forecast and price target.
  • Earnings Growth

    Earnings for MariMed are expected to grow in the coming year, from ($0.04) to ($0.02) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MariMed is -2.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MariMed is -2.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MariMed has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about MariMed's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of MariMed has been sold short.
  • Short Interest Ratio / Days to Cover

    MariMed has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MariMed has recently decreased by 88.36%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    MariMed does not currently pay a dividend.

  • Dividend Growth

    MariMed does not have a long track record of dividend growth.

  • News Sentiment

    MariMed has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for MariMed this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for MRMD on MarketBeat in the last 30 days.
  • MarketBeat Follows

    4 people have added MariMed to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MariMed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.29% of the stock of MariMed is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    0.18% of the stock of MariMed is held by institutions.

  • Read more about MariMed's insider trading history.
Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MRMD Stock News Headlines

MariMed Announces Second Quarter 2026 Earnings Date
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in 50 years - and it has nothing to do with a single stock. According to multiple Wall Street banks, a coming crisis could keep your portfolio in the red for 10 years or longer. Keith Kaplan, CEO of TradeSmith, is sharing what you can do to protect your wealth before it hits.tc pixel
See More Headlines

MRMD Stock Analysis - Frequently Asked Questions

MariMed's stock was trading at $0.0879 on January 1st, 2026. Since then, MRMD stock has decreased by 25.4% and is now trading at $0.0656.

MariMed Inc. (OTCMKTS:MRMD) posted its quarterly earnings data on Wednesday, May, 13th. The company reported ($0.01) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.01). The firm earned $39.48 million during the quarter, compared to the consensus estimate of $38.75 million. MariMed had a negative net margin of 7.82% and a negative trailing twelve-month return on equity of 5.00%.
Read the conference call transcript
.

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MariMed investors own include Canopy Growth (CGC), Innovative Industrial Properties (IIPR), NVIDIA (NVDA), Curaleaf (CURLF), Aurora Cannabis (ACB), Meta Platforms (META) and Tilray Brands (TLRY).

Company Calendar

Last Earnings
5/13/2026
Today
7/15/2026
Next Earnings (Estimated)
8/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:MRMD
Previous Symbol
OTC:MRMD
CIK
1522767
Fax
N/A
Employees
260
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.48 million
Net Margins
-7.82%
Pretax Margin
-5.78%
Return on Equity
-5.00%
Return on Assets
-1.29%

Debt

Debt-to-Equity Ratio
1.67
Current Ratio
0.95
Quick Ratio
0.34

Sales & Book Value

Annual Sales
$159.83 million
Price / Sales
0.16
Cash Flow
$0.02 per share
Price / Cash Flow
2.86
Book Value
$0.13 per share
Price / Book
0.50

Miscellaneous

Outstanding Shares
399,200,000
Free Float
330,180,000
Market Cap
$26.19 million
Optionable
Not Optionable
Beta
1.32
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (OTCMKTS:MRMD) was last updated on 7/15/2026 by MarketBeat.com Staff.
From Our Partners